New data from the accounting platform Xero should give American entrepreneurs one more reason to be optimistic about 2025.

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

International Business Machines Corp. gave a stronger-than-expected revenue growth outlook for the coming years led by the ...

Fast-food restaurant owner Yum Brands is expecting stronger sales growth this year after it moves past challenges in its Middle East markets.

Japan's Toyota Motor is expected to post its second consecutive quarterly profit drop when it reports third-quarter earnings ...

Chipotle Mexican Grill said on Tuesday that if President Donald Trump's proposed tariffs on Mexico go into full effect, the ...

The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Yum! Brands Inc. sales surpassed expectations, powered by growth at Taco Bell as the fast-food chain continues to sidestep a slowdown that has plagued many competitors.

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this ...